“Real life” longevity of implantable cardioverter‐defibrillator devices

Manufacturers of implantable cardioverter‐defibrillators (ICDs) promise a 5‐ to 9‐year projected longevity; however, real‐life data indicate otherwise. The aim of the present study was to assess ICD longevity among 685 consecutive patients over the last 20 years.

[1]  J. Fisher,et al.  Pacemakers and Implantable Cardioverter Defibrillators: , 2004, Pacing and clinical electrophysiology : PACE.

[2]  R. Hauser,et al.  The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. , 2005, Journal of the American College of Cardiology.

[3]  V. Novack,et al.  Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs) , 2012, Clinical Research in Cardiology.

[4]  A. Manolis,et al.  Electrophysiologist‐Implanted Transvenous Cardioverter Defibrillators Using Local Versus General Anesthesia , 2000, Pacing and clinical electrophysiology : PACE.

[5]  Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators. , 2012, Heart rhythm.

[6]  A. Manolis,et al.  Cardiac implantable electronic device lead extraction using the lead-locking device system: keeping it simple, safe, and inexpensive with mechanical tools and local anesthesia , 2017, Anatolian journal of cardiology.

[7]  D. Theuns,et al.  Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  G. Larsen,et al.  Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. , 1992, Journal of the American College of Cardiology.

[9]  M. Schalij,et al.  Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy , 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[10]  D. Cannom,et al.  Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. , 2006, Heart rhythm.

[11]  A. Curnis,et al.  The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  C. Sticherling,et al.  Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. , 2009, Heart rhythm.

[13]  P. J. Wang,et al.  Fully transvenous cardioverter defibrillators: rare need for subcutaneous patch with two newer-generation systems. , 1994, American heart journal.

[14]  A. Manolis,et al.  Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone‐Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis , 2017, Pacing and clinical electrophysiology : PACE.

[15]  D. Stacey,et al.  Estimating the Risks and Benefits of Implantable Cardioverter Defibrillator Generator Replacement: A Systematic Review , 2016, Pacing and clinical electrophysiology : PACE.

[16]  A. Manolis.  Cardiac resynchronization therapy in congestive heart failure: Ready for prime time? , 2004, Heart rhythm.

[17]  W. Maisel,et al.  Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. , 2006, JAMA.

[18]  G. Nickenig,et al.  Real‐World Data on the Lifespan of Implantable Cardioverter‐Defibrillators Depending on Manufacturers and the Amount of Ventricular Pacing , 2012, Journal of cardiovascular electrophysiology.

[19]  M. Biffi,et al.  Device Longevity in a Contemporary Cohort of ICD/CRT‐D Patients Undergoing Device Replacement , 2016, Journal of cardiovascular electrophysiology.

[20]  A. Manolis,et al.  Transvenous defibrillator systems implanted by electrophysiologists in the catheterization laboratory , 1997, Clinical cardiology.

[21]  Giuseppe Boriani,et al.  Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  A. Manolis,et al.  Automatic implantable cardioverter defibrillator. Current status. , 1989 .

[23]  SumChe Man,et al.  Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer. , 2012, Heart rhythm.

[24]  Giuseppe Boriani,et al.  Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  A. Manolis,et al.  Managing infected cardiovascular implantable electronic devices , 2016 .

[26]  B. Wilkoff,et al.  Advances in implantable cardioverter defibrillator therapy , 2016, Expert review of cardiovascular therapy.

[27]  G. Hasenfuss,et al.  Longevity of implantable cardioverter-defibrillators in a single-center population , 2015, Journal of Interventional Cardiac Electrophysiology.

[28]  H. Mond,et al.  The Cardiac Implantable Electronic Device Power Source: Evolution and Revolution , 2014, Pacing and clinical electrophysiology : PACE.

[29]  A. Manolis,et al.  Pectoral Cardioverter Defibrillators: Comparison of Prepectoral and Submuscular Implantation Techniques , 1999, Pacing and clinical electrophysiology : PACE.

[30]  J. Cleland,et al.  The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most? , 2015, European heart journal.

[31]  J. Neuzner,et al.  The mismatch between patient life expectancy and the service life of implantable devices in current cardioverter-defibrillator therapy: a call for larger device batteries , 2015, Clinical Research in Cardiology.

[32]  S. Saba,et al.  Battery longevity from cardiac resynchronization therapy defibrillators: differences between manufacturers and discrepancies with published product performance reports , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.